Pharmacists' Delivery of Education to Prevent Diabetes in the New Orleans Hospitality Industry

February 27, 2026 updated by: Xavier University of Louisiana.

Pharmacists' Delivery of Health Education to Prevent Diabetes in the New Orleans Hospitality Industry Workforce

This is a one-year pilot study focused on prediabetes among hospitality workers in New Orleans, Louisiana. The project will assess prediabetes rates among the target population, evaluate the impact of pharmacist led lifestyle education sessions, the provision of wellness tools, and healthcare resource referrals on participant knowledge and health behaviors. The results obtained from this study will provide enhanced understanding of prediabetes prevalence and interventions to combat health disparities within this population.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Louisiana
      • New Orleans, Louisiana, United States, 70125
        • Xavier University of Louisiana - College of Pharmacy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults age 18-99
  • Hospitality Worker employed within Orleans Parish

Exclusion Criteria:

  • Prior Diagnosis of Diabetes Type I or II
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single Arm - Screening and Intervention Group
Behavioral: Linkage to Care
Resource Referral
Other Names:
  • Primary Care
  • Prevention Program
Other: Educational
Education on risk factors, prevention methods, healthy lifestyle habits.
Other Names:
  • Prediabetes Education
Other: Healthy Lifestyle Tools
Fitness Tracker, Healthy Portion Plate
Other Names:
  • Health Promotion Tools

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant diabetes prevention knowledge as measured by survey
Time Frame: Immediately, 1 month post exposure and 3 months post exposure.
Recall of key health information delivered by pharmacists and pharmacy interns as measured by pre and post scores (0%-100%) on 6 multiple choice item questionnaire.
Immediately, 1 month post exposure and 3 months post exposure.
Prediabetes Risk Rate
Time Frame: At enrollment
Rate of prediabetes risk as calculated by ADA risk calculator and A1c point of care testing
At enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prediabetes Risk Rate Concordance/Reliability
Time Frame: At enrollment
Positive concordance between results of ADA risk calculator and A1c point of care testing
At enrollment
Participants utilization of healthy lifestyle tools as measured by survey
Time Frame: 1 month post exposure and 3 months post exposure.
Participants use of fitness tracker, and healthy portion plate as reported by questionnaire response on a 5 point Likert scale
1 month post exposure and 3 months post exposure.
Participants Utilization of Linkage to Care - Diabetes Prevention Program Enrollment as measured by survey response
Time Frame: 1 month post exposure and 3 months post exposure.
Participants enrollment in a diabetes prevention program as measured by participant survey response.
1 month post exposure and 3 months post exposure.
Participants Utilization of Linkage to Care - Primary Healthcare Seeking as Measured by Survey Response.
Time Frame: 1 month post exposure and 3 months post exposure.
Participants interaction with a recommended primary care facility as measured by participant survey response.
1 month post exposure and 3 months post exposure.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Xavier University of Louisiana.

Investigators

  • Principal Investigator: Brittany Singleton, BA, PharmD, BCPS, BCSCP, Xavier University of Louisiana - College of Pharmacy
  • Principal Investigator: Katrina Nguyen, BS, PharmD, Xavier University of Louisiana - College of Pharmacy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 20, 2025

Primary Completion (Actual)

October 3, 2025

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

April 21, 2025

First Submitted That Met QC Criteria

February 27, 2026

First Posted (Actual)

March 5, 2026

Study Record Updates

Last Update Posted (Actual)

March 5, 2026

Last Update Submitted That Met QC Criteria

February 27, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB1016-25

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe